发明公开
EP1437339A1 SUBSTITUTED BENZOIC ACID DERIVATIVES EXHIBITING NF-KAPPA B INHIBITING ACTIVITY
审中-公开
与NF-KAPPA-B锁效应取代苯甲酸
- 专利标题: SUBSTITUTED BENZOIC ACID DERIVATIVES EXHIBITING NF-KAPPA B INHIBITING ACTIVITY
- 专利标题(中): 与NF-KAPPA-B锁效应取代苯甲酸
-
申请号: EP02765501.8申请日: 2002-09-11
-
公开(公告)号: EP1437339A1公开(公告)日: 2004-07-14
- 发明人: SUZUKI, Kenji , NUNOKAWA, Yoichi
- 申请人: Daiichi Suntory Pharma Co., Ltd. , Daiichi Suntory Biomedical Research Co., Ltd.
- 申请人地址: 5-7-2, Kojimachi Chiyoda-ku Tokyo 102-8530 JP
- 专利权人: Daiichi Suntory Pharma Co., Ltd.,Daiichi Suntory Biomedical Research Co., Ltd.
- 当前专利权人: Daiichi Suntory Pharma Co., Ltd.,Daiichi Suntory Biomedical Research Co., Ltd.
- 当前专利权人地址: 5-7-2, Kojimachi Chiyoda-ku Tokyo 102-8530 JP
- 代理机构: Ford, Michael Frederick
- 优先权: JP2001282255 20010917
- 国际公布: WO2003024913 20030327
- 主分类号: C07C65/24
- IPC分类号: C07C65/24 ; C07C66/00 ; C07C69/94 ; C07C235/84 ; C07D213/55 ; C07D213/56 ; C07D295/18 ; A61K31/167 ; A61K31/192 ; A61K31/235 ; A61K31/4409 ; A61K31/4418 ; A61K31/4453 ; A61K31/4545 ; A61K31/5375 ; A61K31/5377 ; A61P1/00
摘要:
A substituted benzoic acid derivative which is represented by the following formula (I) and has an NF-κB inhibiting action (in the formula, R 3 , R 4 and R 5 each independently represents a hydrogen atom, an alkyl group having 1 to 6 carbon(s) or an alkoxy group having 1 to 6 carbon(s); R 9 and R 10 each independently represents a hydrogen atom, an alkyl group having 1 to 6 carbon(s) or an acyl group having 2 to 11 carbons); R 2 represents an optionally-substituted aromatic hydrocarbon group or an optionally-substituted heterocyclic group; and X represents a carboxyl group which may be esterified or amidated).
or
or
信息查询